NURIA
ERITJA SANCHEZ
CON
![Foto de NURIA](/img/nophoto.png)
![Foto de Hospital Universitari de Bellvitge](/img/noimage_org.png)
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (13)
2024
-
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review
Cancers, Vol. 16, Núm. 1
2023
-
Molecular Pathology of Endometrial Tumors
Molecular Surgical Pathology: Second Edition (Springer International Publishing), pp. 297-321
2022
-
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma
Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259
-
M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors
British Journal of Cancer
-
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer
Cancers, Vol. 14, Núm. 12
2021
-
Endometrial pten deficiency leads to smad2/3 nuclear translocation
Cancers, Vol. 13, Núm. 19
2020
-
Intratumour heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification: a descriptive study
Histopathology, Vol. 76, Núm. 3, pp. 447-460
-
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma
Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265
2019
-
Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma
Virchows Archiv, Vol. 474, Núm. 5, pp. 585-598
-
Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer
Gynecologic Oncology, Vol. 153, Núm. 2, pp. 425-435
2018
-
Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences
Pathobiology, Vol. 85, Núm. 1-2, pp. 35-40
2017
-
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
Autophagy, Vol. 13, Núm. 3, pp. 608-624
-
Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients
Oncotarget, Vol. 8, Núm. 65, pp. 109018-109026